The main focus of my current research is to extend existing deterministic and individual-based mathematical models that can inform malaria eradication strategies - how, where and when should resources be invested to most effectively reduce the global case burden and eventually eradicate Plasmodium parasites?
I also work on determining the cost-effectiveness of the recently recommended RTS,S/AS01 malaria vaccine, relative to scale-up of existing interventions such as insecticide-treated nets and seasonal malaria chemoprevention.
Prior to my post-doc I worked on HIV, sickle cell disease, Burkitt’s lymphoma, cervical cancer, and the RTS,S malaria vaccine. I have spent time living abroad in Kenya and Malawi, working with the National Cancer Institute’s Center for Global Health, national Ministries of Health, and other academic partners. I also serve as an epidemiology consultant for the Pan African Academy of Christian Surgeons (PAACS) and a member of the African Esophageal Cancer Consortium (AfrECC).
et al., 2021, Occurrence and Distribution of Non-falciparum Malaria Parasite Species among Adolescents and Adults in Malawi., The Journal of Infectious Diseases
et al., 2021, Effectiveness of a national mass distribution campaign of long-lasting insecticide-treated nets and indoor residual spraying on clinical malaria in Malawi, 2018-2020., Bmj Global Health, Vol:6
et al., 2020, Asymptomatic Plasmodium falciparum malaria prevalence among adolescents and adults in Malawi, 2015–2016, Scientific Reports, Vol:10, ISSN:2045-2322, Pages:18740-18740
et al., 2020, Household prevalence of P. falciparum, P. vivax, and P. ovale in the Democratic Republic of the Congo, 2013-2014., Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
et al., 2020, Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi., Vaccine, Vol:38, Pages:4079-4087
et al., 2020, Variations in HIV Risk by Young Women’s Age and Partner Age Disparity in Rural South Africa (HPTN 068)., Journal of Acquired Immune Deficiency Syndromes (1999), Vol:83, Pages:350-356